BioCentury
ARTICLE | Company News

Biolipox, Boehringer Ingelheim deal

September 8, 2014 7:00 AM UTC

Orexo AB (SSE:ORX; OTCQX:ORXOY, Uppsala, Sweden) said Boehringer returned all rights to OX-MPI, a preclinical program of prostaglandin E2 (PGE-2) inhibitors in development to treat chronic inflammat...